Adma Biologics (ADMA) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Adma Biologics (ADMA) over the last 6 years, with Sep 2025 value amounting to $0.15.
- Adma Biologics' EPS (Weighted Average and Diluted) changed negligibly% to $0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.86, marking a year-over-year increase of 207.14%. This contributed to the annual value of $0.81 for FY2024, which is 723.08% up from last year.
- As of Q3 2025, Adma Biologics' EPS (Weighted Average and Diluted) stood at $0.15, which was up 7.14% from $0.14 recorded in Q2 2025.
- In the past 5 years, Adma Biologics' EPS (Weighted Average and Diluted) ranged from a high of $0.46 in Q4 2024 and a low of -$0.16 during Q1 2021.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $0.11 (2025), whereas its average is $0.10.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 33.33% in 2023, then spiked by 1,400.00% in 2024.
- Quarterly analysis of 5 years shows Adma Biologics' EPS (Weighted Average and Diluted) stood at -$0.07 in 2021, then rose by 14.29% to -$0.06 in 2022, then crashed by 33.33% to -$0.08 in 2023, then soared by 675.00% to $0.46 in 2024, then remained steady at $0.15 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.15 in Q3 2025, compared to $0.14 in Q2 2025 and $0.11 in Q1 2025.